1/8/2009
Thursday morning

This topic is closed off and you will be taken directly to the website.

Topics taken from open source list. I hope you find this useful.
This site is for our clients only as an information resource.

Our 1990 article reported on recent papers in the peer-reviewed literature and two international symposia, one at the International Agency for Research on Cancer (2) and the other at Harvard University (3), all concluding that chrysotile fibers are less active than amphibole types (crocidolite, amosite, tremolite) of asbestos in the causation of mesothelioma in man. In his summary of the IARC meeting, Sir Richard Doll, an eminent epidemiologist, concluded there is the difference between the effects of chrysotile and amphiboles, which is so great in relation to mesothelioma that it is possible to argue that chrysotile does not cause mesothelioma at all (2). This observation has been supported by numerous peer-reviewed papers and working groups subsequently (4-6).
Mesothelioma, a fatal cancer usually found on the lining of the lung, is specifically recognized in Ontario—as is asbestosis—as arising from exposure to asbestos. Mesothelioma is written into the Compensation Act as a Schedule 4 Disease.
In stating that a threshold of effect has never been found for asbestos, Rall stands behind the outdated one fiber can kill theory of carcinogenesis. However, Rall fails to mention data supporting a threshold for chrysotile in lung cancer (11, asbestosis (12), and mesothelioma (13) as well as a panel report from the Health Effects Institute-Asbestos Research (HEI-AR) detailing animal and in vitro dose-response studies exhibiting no-observed adverse effect levels (NOAELs) for asbestos (14). Our recent work documents a dose-dependent increase in asbestos-induced proto-oncogene activation in mesothelial cells with no induction at lowest concentrations of fibers tested and an enhanced potency of crocidolite asbestos in comparison to chrysotile (15).
Latency periods (time intervals elapsing between first exposure to asbestos and death) were examined in 421 cases of malignant pleural mesothelioma, diagnosed in the Trieste-Monfalcone area, Italy. Occupational data were collected from the patients or from their relatives by personal or telephone interviews. Routine lung sections were examined for asbestos bodies in 370 cases. Latency periods, calculated in 312 cases, ranged from 14 to 72 years (mean 48.7, median 51). Latency periods differed significantly from one occupational group to another. Mean latency periods were 29.6 among insulators, 35.4 among dock workers, 43.7 in a heterogeneous group defined as various, 46.4 in non-shipbuilding industry workers, 49.4 in shipyard workers, 51.7 among women with a history of domestic exposure to asbestos, and 56.2 in people employed in maritime trades. The ANOVA test indicated a correlation between latency periods an.
A series of 421 malignant pleural mesotheliomas, diagnosed in the Trieste-Monfalcone area, northeastern Italy, were reviewed. A large majority of the patients had been employed in naval work (shipbuilding, maritime trades, and dock work). Latency periods (time intervals between first exposure to asbestos and death), showed wide variations from one occupational category to another. Such variations were attributable, but only partly, to differences in the intensity of the exposure to asbestos. Various family cases were identified, including people with and without blood relationships. The data, obtained in the studies on Trieste-Monfalcone mesothelioma, suggest that interactions between asbestos and other factors play a considerable role in the pathogenesis of asbestos-related mesothelioma. ___________________________________________________________ Med Lav 1997 Jul-Aug;88(4):310-5
Mesothelioma Attorney Houston | Mesothelioma Lawyer | Mesothelioma Attorney | Mesotheleoma Attorney Texas | Mesotheleoma | Mesothelioma Settlement | Mesothelioma Treatment | Mesotheliom | Mesothelioma Cancer | Malignant Mesothelioma | Mesothelioma Information | Mesotheleoma Litigation | Mesothlioma Asbestos | Peritoneal Mesothelioma | . |. |. |
(c) Copyright 2009